CASH FLOW STATEMENT
5-Year Projections with Monthly Year 1 Detail

YEAR 1 MONTHLY CASH FLOW (BASE CASE)
Line Item,M1,M2,M3,M4,M5,M6,M7,M8,M9,M10,M11,M12,YEAR 1

OPERATING ACTIVITIES
Net Income,-$290370,-$290370,-$290370,-$187870,-$126370,-$25138,$33039,$66795,$100552,$100552,$100552,$100552,-$708446

Add Back: Non-Cash Items
Depreciation,$45000,$45000,$45000,$45000,$45000,$45000,$45000,$45000,$45000,$45000,$45000,$45000,$540000
Amortization,$8333,$8333,$8333,$8333,$8333,$8333,$8333,$8333,$8333,$8333,$8333,$8333,$100000

Changes in Working Capital
Accounts Receivable,$0,$0,$0,-$22575,-$13545,$0,$0,$0,$0,$0,$0,$0,-$36120
Inventory,$0,$0,$0,-$15000,$0,$0,$0,$0,$0,$0,$0,$0,-$15000
Prepaid Expenses,-$50000,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$50000
Accounts Payable,$0,$0,$0,$25000,$10000,$10000,$5000,$0,$0,$0,$0,$0,$50000
Accrued Expenses,$0,$0,$0,$15000,$5000,$5000,$0,$0,$0,$0,$0,$0,$25000
Deferred Revenue,$0,$0,$0,$30000,$20000,$10000,$0,$0,$0,$0,$0,$0,$60000
CASH FROM OPERATIONS,-$287037,-$237037,-$237037,-$102112,-$51582,$53195,$91372,$120128,$153885,$153885,$153885,$153885,-$34566

INVESTING ACTIVITIES
Property Acquisition,-$1209000,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$1209000
Renovation/Conversion,-$708333,-$708333,-$708333,-$708333,-$708333,-$708335,$0,$0,$0,$0,$0,$0,-$4250000
Medical Equipment,-$250000,-$250000,-$250000,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$750000
Bio-optimization Equipment,-$150000,-$150000,-$150000,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$450000
FF&E,-$333333,-$333333,-$333334,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$1000000
Technology,-$100000,-$100000,-$100000,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$300000
Pre-opening Costs,-$133333,-$133333,-$133334,$0,$0,$0,$0,$0,$0,$0,$0,$0,-$400000
CASH FROM INVESTING,-$2883999,-$1674999,-$1675001,-$708333,-$708333,-$708335,$0,$0,$0,$0,$0,$0,-$10359000

FINANCING ACTIVITIES
Equity Investment,$11000000,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$11000000
Debt Financing,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0
Debt Repayment,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0
CASH FROM FINANCING,$11000000,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$0,$11000000

NET CASH FLOW,$7828964,-$1912036,-$1912038,-$810445,-$759915,-$655140,$91372,$120128,$153885,$153885,$153885,$153885,$606434

CASH BALANCE
Beginning Cash,$0,$7828964,$5916928,$4004890,$3194445,$2434530,$1779390,$1870762,$1990890,$2144775,$2298660,$2452545,$0
Ending Cash,$7828964,$5916928,$4004890,$3194445,$2434530,$1779390,$1870762,$1990890,$2144775,$2298660,$2452545,$2606430,$2606430

5-YEAR ANNUAL CASH FLOW (BASE CASE)
Line Item,Year 1,Year 2,Year 3,Year 4,Year 5

OPERATING ACTIVITIES
Net Income,-$708446,$1924506,$2439792,$2604167,$2750170
Depreciation & Amortization,$640000,$640000,$640000,$640000,$640000
Changes in Working Capital,$33880,-$100000,-$50000,-$25000,-$25000
CASH FROM OPERATIONS,-$34566,$2464506,$3029792,$3219167,$3365170

INVESTING ACTIVITIES
Capital Expenditures,-$10359000,-$200000,-$250000,-$300000,-$350000
Maintenance CapEx,$0,-$100000,-$150000,-$150000,-$200000
CASH FROM INVESTING,-$10359000,-$300000,-$400000,-$450000,-$550000

FINANCING ACTIVITIES
Equity Investment,$11000000,$0,$0,$0,$0
Dividends Paid,$0,$0,-$500000,-$1000000,-$1500000
CASH FROM FINANCING,$11000000,$0,-$500000,-$1000000,-$1500000

NET CASH FLOW,$606434,$2164506,$2129792,$1769167,$1315170

CASH BALANCE
Beginning Cash,$0,$606434,$2770940,$4900732,$6669899
Ending Cash,$606434,$2770940,$4900732,$6669899,$7985069

FREE CASH FLOW ANALYSIS
Metric,Year 1,Year 2,Year 3,Year 4,Year 5
EBITDA,-$23484,$3389294,$4125417,$4360238,$4568815
Less: CapEx,-$10359000,-$300000,-$400000,-$450000,-$550000
Less: Working Capital Change,$33880,-$100000,-$50000,-$25000,-$25000
Less: Taxes Paid,$0,-$824788,-$1045625,-$1116071,-$1178645
FREE CASH FLOW,-$10348604,$2164506,$2629792,$2769167,$2815170

CUMULATIVE FREE CASH FLOW
Year,Annual FCF,Cumulative FCF,Investment Recovery
Year 0 (Investment),-$10867500,-$10867500,-$10867500
Year 1,-$10348604,-$21216104,-$21216104
Year 2,$2164506,-$19051598,-$19051598
Year 3,$2629792,-$16421806,-$16421806
Year 4,$2769167,-$13652639,-$13652639
Year 5,$2815170,-$10837469,-$10837469

CASH RUNWAY ANALYSIS
Metric,Value
Initial Investment Required,$10867500
Year 1 Operating Cash Burn,$34566
Year 1 Ending Cash,$606434
Months of Runway at Year-End,>24 months
Cash Positive Month,Month 6
Cumulative Cash Positive,Month 18

WORKING CAPITAL REQUIREMENTS
Component,Year 1,Year 2,Year 3,Year 4,Year 5
Accounts Receivable (15 days),$175031,$371695,$427590,$456155,$484720
Inventory,$50000,$75000,$90000,$100000,$110000
Prepaid Expenses,$100000,$100000,$100000,$100000,$100000
Less: Accounts Payable,$125000,$175000,$200000,$225000,$250000
Less: Deferred Revenue,$150000,$200000,$225000,$250000,$275000
NET WORKING CAPITAL,$50031,$171695,$192590,$181155,$169720
Change in NWC,$50031,$121664,$20895,-$11435,-$11435

INVESTOR CASH FLOW SCHEDULE
Event,Timing,Amount
Initial Investment,Month 0,$10867500
Cash Flow Year 1,Month 12,-$34566
Cash Flow Year 2,Month 24,$2464506
Cash Flow Year 3,Month 36,$3029792
Cash Flow Year 4,Month 48,$3219167
Cash Flow Year 5,Month 60,$3365170

TERMINAL VALUE (Exit Year 5)
Metric,Conservative,Base,Aggressive
Year 5 EBITDA,$3435062,$4568815,$4801724
Exit Multiple,4.0x,5.0x,6.0x
Terminal Value,$13740248,$22844075,$28810344
Plus: Cash Balance,$5500000,$7985069,$9500000
Enterprise Value,$19240248,$30829144,$38310344
